Orange Book product
CEFOTAXIME EQ 500MG BASE/VIAL
Orange Book ANDA 064200 · FRESENIUS KABI USA LLC · Discontinued
Key facts
| Proprietary name | CEFOTAXIME |
|---|---|
| Active ingredients | CEFOTAXIME SODIUM |
| Strength | EQ 500MG BASE/VIAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Application | ANDA064200 |
| Applicant holder | FRESENIUS KABI USA LLC |
| Marketing status | Discontinued |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Mar 24, 2000 |
At a glance
- None Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.